These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22056299)

  • 1. Travel-associated health risks for patients with inflammatory bowel disease.
    Ben-Horin S; Bujanover Y; Goldstein S; Nadler M; Lang A; Kopylov U; Katz L; Lahat A; Schwartz E; Avidan B
    Clin Gastroenterol Hepatol; 2012 Feb; 10(2):160-5, 165.e1. PubMed ID: 22056299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease.
    García Rodríguez LA; Ruigómez A; Panés J
    Gastroenterology; 2006 May; 130(6):1588-94. PubMed ID: 16697722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of autonomic dysfunction on inflammatory bowel disease.
    Ananthakrishnan AN; Issa M; Barboi A; Jaradeh S; Zadvornova Y; Skaros S; Johnson K; Otterson MF; Binion DG
    J Clin Gastroenterol; 2010 Apr; 44(4):272-9. PubMed ID: 19727003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.
    Gradel KO; Nielsen HL; Schønheyder HC; Ejlertsen T; Kristensen B; Nielsen H
    Gastroenterology; 2009 Aug; 137(2):495-501. PubMed ID: 19361507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in Australians deployed abroad.
    Lee TW; Russell L; Deng M; Gibson PR
    Intern Med J; 2013 Aug; 43(8):919-26. PubMed ID: 23656210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Wajda A; Blanchard JF
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptoms of infectious diseases in immunocompromised travelers: a prospective study with matched controls.
    Baaten GG; Geskus RB; Kint JA; Roukens AH; Sonder GJ; van den Hoek A
    J Travel Med; 2011; 18(5):318-26. PubMed ID: 21896095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of arterial thrombotic events in inflammatory bowel disease.
    Ha C; Magowan S; Accortt NA; Chen J; Stone CD
    Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk behaviors and spectrum of diseases among elderly travelers: a comparison of younger and older adults.
    Alon D; Shitrit P; Chowers M
    J Travel Med; 2010; 17(4):250-5. PubMed ID: 20636598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of colorectal cancer in inflammatory bowel disease.
    Bansal P; Sonnenberg A
    Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Clostridium difficile on inflammatory bowel disease.
    Issa M; Vijayapal A; Graham MB; Beaulieu DB; Otterson MF; Lundeen S; Skaros S; Weber LR; Komorowski RA; Knox JF; Emmons J; Bajaj JS; Binion DG
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
    Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat waves, incidence of infectious gastroenteritis, and relapse rates of inflammatory bowel disease: a retrospective controlled observational study.
    Manser CN; Paul M; Rogler G; Held L; Frei T
    Am J Gastroenterol; 2013 Sep; 108(9):1480-5. PubMed ID: 23939628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of postoperative deep vein thrombosis and pulmonary embolism in patients with inflammatory bowel disease: a study of National Surgical Quality Improvement Program patients.
    Merrill A; Millham F
    Arch Surg; 2012 Feb; 147(2):120-4. PubMed ID: 22006853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
    Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
    Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
    Gupta G; Gelfand JM; Lewis JD
    Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
    Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
    Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization.
    Weng X; Liu L; Barcellos LF; Allison JE; Herrinton LJ
    Am J Gastroenterol; 2007 Jul; 102(7):1429-35. PubMed ID: 17437504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.